Merck Agrees to Pay $100 Million in NuvaRing Settlement

Merck may pay $100 million to settle thousands of lawsuits over the safety of its NuvaRing contraceptive as long as enough women agree to participate.  The settlement may resolve as many as 3,800 cases in federal and state courts.  The lawsuits alleged that Merck knew while selling the product that it posed a higher risk risk of heart-attacking blood clots than competing products.  A New Jersey judge gave preliminary approval of the settlement, subject to 95% of the plaintiffs participating in the settlement.  If you beleive you have been injured by a drug or medical device, we can help.  Call1-866-665-4995 for a free consultation.